New approaches for inner ear therapy with glutamate antagonists

Acta Oto-Laryngologica

Volumn 119, Issue 2, 1999, Pages 174-178

  Obstreicher, Elmar ^a,b   Arnold, Wolfgang ^a   Ehrenberger, Klaus ^c   Felix, Dominik ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF BERN   (Switzerland)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

Caroverine; Glutamate antagonists; Inner hair cell; Local therapy; Memantine; Micropump

Indexed keywords

ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; CAROVERINE; GLUTAMATE RECEPTOR ANTAGONIST; GLUTAMIC ACID; MEMANTINE; N METHYL DEXTRO ASPARTIC ACID;

ARTICLE; DRUG DELIVERY SYSTEM; DRUG EFFECT; HAIR CELL; INNER EAR DISEASE; ISCHEMIA; NEUROTOXICITY; NEUROTRANSMISSION; NOISE INJURY; PRIORITY JOURNAL; SENSORY NERVE;

ANIMALS; COCHLEAR DISEASES; EXCITATORY AMINO ACID ANTAGONISTS; GUINEA PIGS; HAIR CELLS, INNER; INFUSION PUMPS, IMPLANTABLE; IONTOPHORESIS; MEMANTINE; NEURONS, AFFERENT; QUINOXALINES;

EID: 0032917936     PISSN: 00016489     EISSN: None     Source Type: Journal    
DOI: 10.1080/00016489950181611     Document Type: Article

References (21)

1. Eybalin M. Neurotransmitter and neuromodulators in the mammalian cochlea. Physiol Rev 1993; 73: 309-73.
2. Ehrenberger K, Felix D. Glutamate receptors in the afferent cochlear neurotransmission in guinea pigs. Hear Res 1991; 52: 73-80.
3. Pujol R, Puel J-L, D'Aldin CG, Eybalin M. Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol (Stockh) 1993; 113: 330-4.
4. Lipton SA, Rosenberg PA. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 1994; 330: 613-22.
5. Fischer P-A, Jacobi P, Schneider E, Schönberger B. Die Wirkung intravenöser Gaben von Memantine bei Parkinson-Kranken. Drug Res 1977; 27: 1487-589.
6. Ditzler K. Efficacy and tolerability of memantine in patients with dementia syndrome. Drug Res 1991; 41: 773-80.
7. Bormann J. Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol 1989; 166: 591-2.
8. Kornhuber J, Bormann J, Retz W, Hübers M, Riederer P. Memantine displaces [3H] MK-801 at therapeutic concentrations in postmortem human frontal cortex. Eur J Pharmacol 1989; 166: 589-90.
9. Chen H-SV, Pellegrini JW, Aggarwal SK, et al. Open-channel block of N-methyl-D-aspartate (NMDA) responses by Memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci 1992; 12: 4427-36.
10. Erdö SL, Schäfer M. Memantine is highly potent in protecting cortical cultures against excitotoxic cell death evoked by glutamate and N-methyl-D-aspartate. Eur J Pharmacol 1991; 198: 215-7.
11. Frankiewicz T, Potier B, Bashir ZI, Collingridge GL, Parsons CG. Effects of memantine and MK-801 on NMDA-induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices. Br J Pharmacol 1996; 117: 689-97.
12. Seif el Nasr M, Peruche B, Rossberg C, Mennel HD, Krieglstein J. Neuroprotective effect of memantine demonstrated in vivo and in vitro. Eur J Pharmacol 1990; 185: 19-24.
13. Weller M, Finiels-Marlier F, Paul SM. NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine. Brain Res 1993; 613: 143-8.
14. Oestreicher E, Arnold W, Ehrenberger K, Felix D. Memantine suppresses the glutamatergic neurotransmission of mammalian inner hair cells. ORL 1998; 60: 18-21.
15. Ehrenberger K, Felix D. Caroverine depresses the activity of cochlear glutamate receptors in guinea pigs: in vivo model for drug-induced neuroprotection? Neuropharmacology 1992; 1: 1259-63.
16. Koppi S, Eberhardt G, Haller R, König P. Calcium-channel-blocking agent in the treatment of acute alcohol-withdrawal - caroverine versus meprobamate in a randomized double blind study. Neuropsychobiology 1987; 17: 49-52.
17. Saletu B, Grunberger J, Anderer P, Linzmayer L, König P. On the cerebro-protective effects of caroverine, a calcium-channel blocker and antiglutamatergic drug: double-blind, placebo-controlled, EEG mapping and psychometric studies under hypoxia. Br J Clin Pharmacol 1996; 41: 89-99.
18. Denk DM, Heinzl H, Franz P, Ehrenberger K. Caroverine in tinnitus treatment. A placebo-controlled blind study. Acta Otolaryngol (Stockh) 1997; 117: 825-30.
19. Oestreicher E, Arnold W, Ehrenberger K, Felix D. Dopamine regulates the glutamatergic inner hair cell activity in guinea pigs. Hear Res 1997; 107: 46-52.
20. Ehrenberger K, Felix D. Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: A survey. Acta Otolaryngol (Stockh) 1995; 115: 236-40.
21. Brown JN, Miller JM, Altschuler RA, Nuttall AL. Osmotic pump implant for chronic infusion of drugs into the inner ear. Hear Res 1993; 70: 167-72.